[PDF] Top 20 ADVANCES IN ANTI-TUBERCULOSIS DRUGS

... M. tuberculosis strains, displaying minimal inhibitory concentrations equal to or lower than those of isoniazid and rifampicin The clinical activity of bedaquiline validates ATP synthase as a highly vulnerable ... See full document

... It is critical to use susceptibility testing to screen for resistance to specific antibiotics for the detection of MDR-TB and XDR-TB so that treatment regimen could be designed specifically on the basis of the detection ... See full document

... HepG2 cells were seeded in 24 well plates at a density of 3 x 10 4 cells/well. At confluence cells were treated for 24 hours with the anti-TB drugs: RIF at 0.1 and 0.5 mM, INH at 10 and 70 mM, and PZA at 10 ... See full document

... first-line anti-TB drugs (rifampicin, isoniazid, streptomycin and ethambutol) and second-line anti-TB drugs (ofloxacin, kanamycin and ...the anti-tuberculosis drugs are: ... See full document

... Dendrimers are nano-sized, radially symmetric molecules with well-defined, homogeneous and monodisperse structure consisting of tree-like arms or branches. With the size ranging from 1 to 10 nm, dendrimers with different ... See full document

... The study of the results of surgical treatment in the follow-up period revealed that relapses were registered re- liably more frequently one year later after completion of the treatment of patients with MDR TB operated ... See full document

... Our study also found that the proportion of resistance to anti-TB drugs within Beijing strains family was significantly higher than non-Beijing strains family.. This is consistent with p[r] ... See full document

... This was a descripti ve study performed prospectively from 1994 to 1997 on hospitalized patients diagnosed as having tuberculosis in Hospitals affiliated to Shahid Beheshti University of Medical Sciences. During ... See full document

... the drugs develops due to an inadequate regimen, poor quality drugs and interrupted treatment with anti TB ...line drugs (SLDs) recommended by WHO 5 ... See full document

... M. tuberculosis infection is a host immune-response to the pathogen itself in combination with the action of the cocktail of anti-TB drugs ... See full document

... Mycobacterium tuberculosis complex: M. tuberculosis, ...M. tuberculosis does not produce significant amounts of pigment, has a buff-colored, smooth surface appearance, and biochemically produces ... See full document

... dose anti-TB drug regimens, the exact mechanisms underlying the effectiveness of such treatment methods is yet to ...(M. tuberculosis) and host interaction and clini- cal manifestation of the ...dose, ... See full document

... of tuberculosis (TB) treatment failure, death, and relapse compared to patients without ...Mycobacterium tuberculosis that was resistant to any first-line drug were ... See full document

... In sum, across 17 countries from the Middle East, the authors reported wide differences in the prevalence rate of mono, any, and multidrug resistance in both new and previously treated TB patients. The present systematic ... See full document

... Tuberculosis has been a significant health hazard in India, but the change in its nature with higher prevalence of MDR-Tb has made it more important to do more research in this field to produce regional data. Such ... See full document

... For the pediatric age data are still very scarce. In a large longitudinal series of children with inflammatory bowel disease (72 patients, 165 QTF-G tests), indeter- minate QTF-G results (10 %) were associated with cor- ... See full document

... treatment, tuberculosis (TB) still accounts for millions cases of active disease and deaths ...Mycobacterium tuberculosis to anti-TB drugs; Isoniazid (INH), Rifampicin (RIF), Streptomycin ... See full document

... of anti-tuberculosis ...front-line drugs used in antituberculosis therapy, have been known to be potentially hepatotoxic and may lead to drug-induced liver injury [4,5] by production of many ... See full document

... core drugs driving the ...core drugs, but only as powerful companion drugs protecting the ...second-line drugs as ...these drugs was found among the Bangladesh ... See full document

... Choice of study regimen and choice of comparator The intention of the study was to evaluate the safety and efficacy of the Bangladesh regimen in a randomized con- trolled trial in comparison to the WHO recommended ... See full document